Allos is a biopharmaceutical company focused on developing and commercializing innovative drugs for improving cancer treatments. home about allos product portfolio science/technology investor relations newsroom join us online resources site map contact us Allos Therapeutics Appoints Michael D. Casey, Former President and CEO of Matrix, to Board of Directors ...